In focus
Latest feed
India's Landmark Approval: Wegovy Cleared for MASH, a Serious Liver Condition
Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians
Abbott Laboratories: Is the Market Missing a Contrarian Gem Ahead of Q2 Earnings?
The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid
